John Tellew

This inventor holds 16 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 5 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Array Biopharma Inc., Novartis Ag, Irm LLC. Active years: 2012-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Tellew. Retrieved from https://idiyas.com/inventor/john-tellew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 5)

% Patents Active = 87.5

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 7.8

ph-index = 6

Forward Citations = 93(Granted Patents)

Company Filing History:

Scripps Research Institute

patents

where one patent can have more than one assignee

Years Active: 2012-2023

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

Hematopoietic Stem Cells

Sulfonamides

Compositions

Compounds

Inhibitors

Therapeutics

Pharmaceuticals

Biochemistry

Cell Expansion

Drug Development

Cancer Treatment

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49556 - Compounds and compositions as protein kinase inhibitors (2023-06-19),

2. 10576080 - Compounds and compositions as protein kinase inhibitors (2020-03-03),

3. 10568884 - Compounds and compositions as protein kinase inhibitors (2020-02-25),

4. 10005761 - Compounds and compositions as protein kinase inhibitors (2018-06-26),

5. 9850230 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

6. 9850229 - Compounds and compositions as protein kinase inhibitors (2017-12-26),

7. 9593100 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

8. 9593099 - Compounds and compositions as protein kinase inhibitors (2017-03-14),

9. 9580426 - Compounds that expand hematopoietic stem cells (2017-02-28),

10. 9314464 - Compounds and compositions as protein kinase inhibitors (2016-04-19),

11. 9181238 - N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors (2015-11-10),

12. 8927281 - Method for expanding hematopoietic stem cells (2015-01-06),

13. 8859548 - Compounds and compositions as protein kinase inhibitors (2014-10-14),

14. 8563553 - Compounds and compositions as protein kinase inhibitors (2013-10-22),

15. 8501758 - Compounds and compositions as protein kinase inhibitors (2013-08-06),

Title: The Innovative Journey of John Tellew

Introduction: John Tellew, a visionary inventor based in La Jolla, CA, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: John Tellew holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: Throughout his illustrious career, John Tellew has been recognized for his pioneering work in developing cutting-edge technologies that have revolutionized various industries. His commitment to pushing the boundaries of innovation has led to the creation of solutions that address complex challenges.

Collaborations: John Tellew has collaborated with leading research institutions, universities, and tech companies to further his inventions and bring them to market. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: John Tellew's passion for innovation, coupled with his relentless drive to make a positive impact on society, sets him apart as a trailblazing inventor whose work continues to inspire future generations in the field of technology.

Profile summary based on public USPTO records.